Yüklüyor......
Hepatocellular carcinoma in a gene therapy research subject with ornithine transcarbamylase deficiency
A 66 year old woman who is a manifesting heterozygote for ornithine transcarbamylase deficiency (OTCD) presented with hepatocellular carcinoma (HCC). Fourteen years prior to this presentation she participated in a phase I gene therapy study which used an adenoviral vector, thought to be non-oncogeni...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3273986/ https://ncbi.nlm.nih.gov/pubmed/22129577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgme.2011.10.016 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|